Stephens Consulting’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.83K | Hold |
1,000
| – | – | ﹤0.01% | 407 |
|
|
2025
Q1 | $5.75K | Hold |
1,000
| – | – | ﹤0.01% | 375 |
|
|
2024
Q4 | $4.99K | Hold |
1,000
| – | – | ﹤0.01% | 410 |
|
|
2024
Q3 | $5.39K | Hold |
1,000
| – | – | ﹤0.01% | 390 |
|
|
2024
Q2 | $3.31K | Hold |
1,000
| – | – | ﹤0.01% | 450 |
|
|
2024
Q1 | $3.27K | Hold |
1,000
| – | – | ﹤0.01% | 396 |
|
|
2023
Q4 | $3.51K | Hold |
1,000
| – | – | ﹤0.01% | 400 |
|
|
2023
Q3 | $6.68K | Hold |
1,000
| – | – | ﹤0.01% | 354 |
|
|
2023
Q2 | $8.39K | Hold |
1,000
| – | – | ﹤0.01% | 326 |
|
|
2023
Q1 | $9.93K | Hold |
1,000
| – | – | 0.01% | 318 |
|
|
2022
Q4 | $6.96K | Hold |
1,000
| – | – | ﹤0.01% | 342 |
|
|
2022
Q3 | $5.34K | Hold |
1,000
| – | – | ﹤0.01% | 400 |
|
|
2022
Q2 | $3.99K | Hold |
1,000
| – | – | ﹤0.01% | 420 |
|
|
2022
Q1 | $4.45K | Sell |
1,000
-1,000
| -50% | -$4.45K | ﹤0.01% | 446 |
|
|
2021
Q4 | $8K | Buy |
+2,000
| New | +$8K | 0.01% | 415 |
|